Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€47.90

€47.90

1.580%
0.745
1.580%
€55.00

€55.00

 
27.01.22 / Tradegate WKN: 852009 / Symbol: PFE / Name: Pfizer / Stock / Pharmaceuticals / Large Cap /
Latest predictions
€78.00
03.01.22
-6.05%
buy
26.12.21
-8.85%
buy
€55.00
22.12.21
-8.78%
buy
€45.00
18.12.21
-9.59%
€55.00
13.12.21
-2.69%
buy
13.12.21
1.18%
buy
Best running prediction
€35.00
21.03.21
63.64%
buy
Your prediction

Pfizer Inc. Stock

Pfizer Inc. gained 1.580% today.
We see a rather positive sentiment for Pfizer Inc. with 13 Buy predictions and 2 Sell predictions.
As a result the target price of €55.00 shows a slightly positive potential of 14.823% compared to the current price of €47.90 for Pfizer Inc..
For the coming years our community has positive and negative things to say abot the Pfizer Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Conscious of the environment" there were negative voices in the community.

Pros and Cons of Pfizer Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Pfizer Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Pfizer Inc. 1.580% 0.188% -8.378% 59.907% -5.986% 42.296% 71.781%
Eli Lilly Corp. 0.760% -1.255% -13.588% 23.805% -13.869% 110.589% 202.134%
Merck & Co. Inc. 2.900% 1.204% 6.907% 13.292% 6.200% 12.920% 25.486%
AbbVie Inc. 2.090% 3.689% 2.781% 43.675% 2.470% 72.825% 117.938%

Comments

Buy Pfizer Inc.
Show more

Buy Pfizer Inc.
Show more

Sell Pfizer Inc.
Show more

Other discussions about Pfizer Inc. Stock

Trading Pfizer Inc.

Trading Pfizer Inc.

New thread Forum

News

Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatmenthttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Receives CHMP Positive Opinion for Novel COVID-19 Oral Treatment


Pfizer Inc. (NYSE: PFE) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the conditional

 Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Agehttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
 Pfizer and BioNTech Initiate Study to Evaluate Omicron-Based COVID-19 Vaccine in Adults 18 to 55 Years of Age


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine

Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiencyhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency


Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Biologics License